165 related articles for article (PubMed ID: 8744510)
1. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward.
Mayall B; Martin R; Keenan AM; Irving L; Leeson P; Lamb K
J Hosp Infect; 1996 Apr; 32(4):257-66. PubMed ID: 8744510
[TBL] [Abstract][Full Text] [Related]
2. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
3. MRSA patients: proven methods to treat colonization and infection.
Boyce JM
J Hosp Infect; 2001 Aug; 48 Suppl A():S9-14. PubMed ID: 11759035
[TBL] [Abstract][Full Text] [Related]
4. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients.
Ridenour G; Lampen R; Federspiel J; Kritchevsky S; Wong E; Climo M
Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1155-61. PubMed ID: 17828692
[TBL] [Abstract][Full Text] [Related]
5. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.
Kauffman CA; Terpenning MS; He X; Zarins LT; Ramsey MA; Jorgensen KA; Sottile WS; Bradley SF
Am J Med; 1993 Apr; 94(4):371-8. PubMed ID: 8475930
[TBL] [Abstract][Full Text] [Related]
6. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward.
Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S
J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
8. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
[TBL] [Abstract][Full Text] [Related]
9. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride.
Rohr U; Mueller C; Wilhelm M; Muhr G; Gatermann S
J Hosp Infect; 2003 Aug; 54(4):305-9. PubMed ID: 12919762
[TBL] [Abstract][Full Text] [Related]
11. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N
J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473
[TBL] [Abstract][Full Text] [Related]
12. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
13. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim HF; Vos MC
Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
[TBL] [Abstract][Full Text] [Related]
14. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin.
Back NA; Linnemann CC; Staneck JL; Kotagal UR
Infect Control Hosp Epidemiol; 1996 Apr; 17(4):227-31. PubMed ID: 8935730
[TBL] [Abstract][Full Text] [Related]
15. The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit.
Barrett SP
J Hosp Infect; 1990 Feb; 15(2):137-42. PubMed ID: 1969435
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
17. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.
Wilcox MH; Hall J; Pike H; Templeton PA; Fawley WN; Parnell P; Verity P
J Hosp Infect; 2003 Jul; 54(3):196-201. PubMed ID: 12855234
[TBL] [Abstract][Full Text] [Related]
18. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin.
Darouiche R; Wright C; Hamill R; Koza M; Lewis D; Markowski J
Antimicrob Agents Chemother; 1991 Aug; 35(8):1612-5. PubMed ID: 1929333
[TBL] [Abstract][Full Text] [Related]
19. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
Henderson DK
Am J Med; 2006 Jun; 119(6 Suppl 1):S45-52; discussion S62-70. PubMed ID: 16735151
[TBL] [Abstract][Full Text] [Related]
20. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.
Bertino JS
Am J Health Syst Pharm; 1997 Oct; 54(19):2185-91. PubMed ID: 9331438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
